Drug‐induced phospholipidosis
Tóm tắt
Drug‐induced phospholipidosis is characterized by intracellular accumulation of phospholipids with lamellar bodies, most likely from an impaired phospholipid metabolism of the lysosome. Organs affected by phospholipidosis exhibit inflammatory reactions and histopathological changes. Despite significant advances in the understanding of drug‐altered lipid metabolism, the relationship between impaired phospholipid metabolism and drug‐induced toxicity remains enigmatic. Here we review molecular features of inheritable lysosomal storage disorders as a molecular mimicry of drug‐induced phospholipidosis for an improved understanding of adverse drug reaction.
Từ khóa
Tài liệu tham khảo
Kodavanti U.P., 1990, Cationic amphiphilic drugs and phospholipid storage disorder, Pharmacol. Rev., 42, 327
Hammond T.G., 1997, Gentamicin inhibits rat renal cortical homotypic endosomal fusion: role of megalin, Am. J. Physiol., 272, F117
Joshi U.M., 1988, Types of interaction of amphiphilic drugs with phospholipid vesicles, J. Pharmacol. Exp. Ther., 246, 150
Hostetler K.Y., 1984, Molecular studies of the induction of cellular phospholipidosis by cationic amphiphilic drugs, Fed. Proc., 43, 2582
Kishore B.K., 1996, Mechanism of the thesaurismosis and altered lysosomal dynamics induced by poly-D-glutamic acid in kidney proximal tubular cells, Lab. Invest., 74, 1025
Reasor M.J., 1984, Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs, Fed. Proc., 43, 2578
Bolt M.W., 2001, Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity, J. Pharmacol. Exp. Ther., 298, 1280